BRIEF-Teradyne Reports Revenue Growth in Q2 and First Half 2016
July 27, 2016 at 18:02 PM EDT
* Guidance for Q3 of 2016 is revenue of $375 million to $405 million,
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.